Cumberland Pharmaceuticals Inc (CPIX) stock
CPIXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 7, 2026Score 5/3074% above fair value
$6.63+0.51 (+8.33%)
Close on Nov 12, 2026Market cap $99.34MP/E –Yield –
Cumberland Pharmaceuticals total assets
Total assets on the balance sheet at the end of each period.
Cumberland Pharmaceuticals's total assets was $62.88M at Jun 30, 2026. For fiscal 2025 it was $76.82M, up 1.6% from the year before. Over ten years it grew -1.8% a year on average. The highest annual figure on record is $112.69M in fiscal 2018.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $76.82M | +1.6% |
| FY2024 | Dec 31, 2024 | $75.58M | -7.6% |
| FY2023 | Dec 31, 2023 | $81.78M | -12.0% |
| FY2022 | Dec 31, 2022 | $92.93M | +10.0% |
| FY2021 | Dec 31, 2021 | $84.46M | -12.4% |
| FY2020 | Dec 31, 2020 | $96.46M | -7.7% |
| FY2019 | Dec 31, 2019 | $104.55M | -7.2% |
| FY2018 | Dec 31, 2018 | $112.69M | +20.9% |
| FY2017 | Dec 31, 2017 | $93.23M | -0.2% |
| FY2016 | Dec 31, 2016 | $93.40M | +1.6% |
| FY2015 | Dec 31, 2015 | $91.92M | -3.7% |
| FY2014 | Dec 31, 2014 | $95.41M | +8.9% |
| FY2013 | Dec 31, 2013 | $87.61M | -11.1% |
| FY2012 | Dec 31, 2012 | $98.59M | +3.2% |
| FY2011 | Dec 31, 2011 | $95.52M | +3.8% |
| FY2010 | Dec 31, 2010 | $92.05M | – |
Quarterly total assets
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $62.88M | -7.4% |
| Q1 FY2026 | Mar 31, 2026 | $71.00M | +1.5% |
| Q4 FY2025 | Dec 31, 2025 | $76.82M | +1.6% |
| Q3 FY2025 | Sep 30, 2025 | $65.90M | -14.1% |
| Q2 FY2025 | Jun 30, 2025 | $67.91M | -13.5% |
| Q1 FY2025 | Mar 31, 2025 | $69.94M | -14.2% |
| Q4 FY2024 | Dec 31, 2024 | $75.58M | -7.6% |
| Q3 FY2024 | Sep 30, 2024 | $76.75M | -12.5% |
| Q2 FY2024 | Jun 30, 2024 | $78.52M | -12.1% |
| Q1 FY2024 | Mar 31, 2024 | $81.51M | -8.9% |
| Q4 FY2023 | Dec 31, 2023 | $81.78M | -12.0% |
| Q3 FY2023 | Sep 30, 2023 | $87.75M | -3.3% |
| Q2 FY2023 | Jun 30, 2023 | $89.38M | -3.4% |
| Q1 FY2023 | Mar 31, 2023 | $89.47M | -7.5% |
| Q4 FY2022 | Dec 31, 2022 | $92.93M | +10.0% |
| Q3 FY2022 | Sep 30, 2022 | $90.78M | +3.7% |
| Q2 FY2022 | Jun 30, 2022 | $92.52M | +4.1% |
| Q1 FY2022 | Mar 31, 2022 | $96.70M | +3.6% |
| Q4 FY2021 | Dec 31, 2021 | $84.46M | -12.4% |
| Q3 FY2021 | Sep 30, 2021 | $87.57M | -8.8% |
| Q2 FY2021 | Jun 30, 2021 | $88.85M | -8.9% |
| Q1 FY2021 | Mar 31, 2021 | $93.35M | -4.2% |
| Q4 FY2020 | Dec 31, 2020 | $96.46M | -7.7% |
| Q3 FY2020 | Sep 30, 2020 | $96.01M | -7.5% |
| Q2 FY2020 | Jun 30, 2020 | $97.52M | -9.3% |
| Q1 FY2020 | Mar 31, 2020 | $97.42M | -15.0% |
| Q4 FY2019 | Dec 31, 2019 | $104.55M | -7.2% |
| Q3 FY2019 | Sep 30, 2019 | $103.77M | +18.7% |
| Q2 FY2019 | Jun 30, 2019 | $107.55M | +18.9% |
| Q1 FY2019 | Mar 31, 2019 | $114.62M | +25.8% |
| Q4 FY2018 | Dec 31, 2018 | $112.69M | +20.9% |
| Q3 FY2018 | Sep 30, 2018 | $87.43M | -3.2% |
| Q2 FY2018 | Jun 30, 2018 | $90.44M | +3.0% |
| Q1 FY2018 | Mar 31, 2018 | $91.09M | -0.8% |
| Q4 FY2017 | Dec 31, 2017 | $93.23M | -0.2% |
| Q3 FY2017 | Sep 30, 2017 | $90.35M | -0.8% |
| Q2 FY2017 | Jun 30, 2017 | $87.80M | – |
| Q1 FY2017 | Mar 31, 2017 | $91.86M | – |
| Q4 FY2016 | Dec 31, 2016 | $93.40M | – |
| Q3 FY2016 | Sep 30, 2016 | $91.07M | – |
See a number that looks wrong?